These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 39404232)
1. Disruption of PHF6 Peptide Aggregation from Tau Protein: Mechanisms of Palmatine Chloride in Preventing Early PHF6 Aggregation. Fagnen C; Giovannini J; Vignol T; Since M; Catto M; Voisin-Chiret AS; Sopkova-de Oliveira Santos J ACS Chem Neurosci; 2024 Nov; 15(21):3981-3990. PubMed ID: 39404232 [TBL] [Abstract][Full Text] [Related]
2. On the Tracks of the Aggregation Mechanism of the PHF6 Peptide from Tau Protein: Molecular Dynamics, Energy, and Interaction Network Investigations. Fagnen C; Giovannini J; Catto M; Voisin-Chiret AS; Sopkova-de Oliveira Santos J ACS Chem Neurosci; 2022 Oct; 13(19):2874-2887. PubMed ID: 36153969 [TBL] [Abstract][Full Text] [Related]
3. Integrating in vitro and in silico approaches to evaluate the "dual functionality" of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils. Haj E; Losev Y; Guru KrishnaKumar V; Pichinuk E; Engel H; Raveh A; Gazit E; Segal D Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1565-1575. PubMed ID: 29634991 [TBL] [Abstract][Full Text] [Related]
4. Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics Simulation. Liu H; Zhong H; Liu X; Zhou S; Tan S; Liu H; Yao X ACS Chem Neurosci; 2019 Dec; 10(12):4810-4823. PubMed ID: 31661961 [TBL] [Abstract][Full Text] [Related]
5. Investigating the Theranostic Potential of Graphene Quantum Dots in Alzheimer's Disease. Walton-Raaby M; Woods R; Kalyaanamoorthy S Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298426 [TBL] [Abstract][Full Text] [Related]
6. Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer's disease-like symptoms in animal model. Viswanathan GK; Shwartz D; Losev Y; Arad E; Shemesh C; Pichinuk E; Engel H; Raveh A; Jelinek R; Cooper I; Gosselet F; Gazit E; Segal D Cell Mol Life Sci; 2020 Jul; 77(14):2795-2813. PubMed ID: 31562564 [TBL] [Abstract][Full Text] [Related]
7. Membrane-mediated fibrillation and toxicity of the tau hexapeptide PHF6. Fanni AM; Vander Zanden CM; Majewska PV; Majewski J; Chi EY J Biol Chem; 2019 Oct; 294(42):15304-15317. PubMed ID: 31439664 [TBL] [Abstract][Full Text] [Related]
8. Deciphering the Role of ATP on PHF6 Aggregation. Pal S; Roy R; Paul S J Phys Chem B; 2022 Jul; 126(26):4761-4775. PubMed ID: 35759245 [TBL] [Abstract][Full Text] [Related]
9. Potent Tau Aggregation Inhibitor D-Peptides Selected against Tau-Repeat 2 Using Mirror Image Phage Display. Malhis M; Kaniyappan S; Aillaud I; Chandupatla RR; Ramirez LM; Zweckstetter M; Horn AHC; Mandelkow E; Sticht H; Funke SA Chembiochem; 2021 Nov; 22(21):3049-3059. PubMed ID: 34375027 [TBL] [Abstract][Full Text] [Related]
10. Identification of Aggregation Mechanism of Acetylated PHF6* and PHF6 Tau Peptides Based on Molecular Dynamics Simulations and Markov State Modeling. Shah SJA; Zhang Q; Guo J; Liu H; Liu H; Villà-Freixa J ACS Chem Neurosci; 2023 Nov; 14(21):3959-3971. PubMed ID: 37830541 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of tau self-aggregation and neurotoxicity. Farías G; Cornejo A; Jiménez J; Guzmán L; Maccioni RB Curr Alzheimer Res; 2011 Sep; 8(6):608-14. PubMed ID: 21605046 [TBL] [Abstract][Full Text] [Related]
12. Deciphering the Inhibitory Mechanism of Naphthoquinone-Dopamine on the Aggregation of Tau Core Fragments PHF6* and PHF6. Zou Y; Qi B; Tan J; Guan L; Zhang Q; Sun Y; Huang F ACS Chem Neurosci; 2023 Sep; 14(17):3265-3277. PubMed ID: 37585669 [TBL] [Abstract][Full Text] [Related]
13. Atomistic Insights into the Inhibitory Mechanism of Tyrosine Phosphorylation against the Aggregation of Human Tau Fragment PHF6. Zou Y; Guan L; Tan J; Qi B; Wang Y; Zhang Q; Sun Y J Phys Chem B; 2023 Jan; 127(1):335-345. PubMed ID: 36594671 [TBL] [Abstract][Full Text] [Related]
14. Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity. Frenkel-Pinter M; Tal S; Scherzer-Attali R; Abu-Hussien M; Alyagor I; Eisenbaum T; Gazit E; Segal D J Alzheimers Dis; 2016; 51(1):165-78. PubMed ID: 26836184 [TBL] [Abstract][Full Text] [Related]
15. Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells. Pickhardt M; Gazova Z; von Bergen M; Khlistunova I; Wang Y; Hascher A; Mandelkow EM; Biernat J; Mandelkow E J Biol Chem; 2005 Feb; 280(5):3628-35. PubMed ID: 15525637 [TBL] [Abstract][Full Text] [Related]
16. Effect of Trehalose and Ceftriaxone on the Stability of Aggregating-Prone Tau Peptide Containing PHF6* Sequence: An SRCD Study. Honisch C; Torni F; Hussain R; Ruzza P; Siligardi G Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328353 [TBL] [Abstract][Full Text] [Related]
17. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies. Navarrete LP; Pérez P; Morales I; Maccioni RB Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of tau amyloid formation and disruption of its preformed fibrils by Naphthoquinone-Dopamine hybrid. Paul A; Viswanathan GK; Huber A; Arad E; Engel H; Jelinek R; Gazit E; Segal D FEBS J; 2021 Jul; 288(14):4267-4290. PubMed ID: 33523571 [TBL] [Abstract][Full Text] [Related]
19. Selection of a d-Enantiomeric Peptide Specifically Binding to PHF6 for Inhibiting Tau Aggregation in Transgenic Mice. Zhang X; Zhang X; Zhong M; Zhao P; Guo C; Li Y; Wang T; Gao H ACS Chem Neurosci; 2020 Dec; 11(24):4240-4253. PubMed ID: 33284003 [TBL] [Abstract][Full Text] [Related]
20. Structural insights into the co-aggregation of Aβ and tau amyloid core peptides: Revealing potential pathological heterooligomers by simulations. Li X; Chen Y; Yang Z; Zhang S; Wei G; Zhang L Int J Biol Macromol; 2024 Jan; 254(Pt 2):127841. PubMed ID: 37924907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]